Although cardiovascular therapeutics like angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and aldosterone antagonist [9], [10] administered concomitantly showed beneficial effects in slowing down the progression of CHF, however, the mortality and morbidity of patients with CHF remained high. The gene discussed is ACE; the disease is congestive heart failure.